Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Canandaigua National Bank & Trust Co. Acquires Shares of 5,547 Gilead Sciences, Inc. $GILD
Canandaigua National Bank & Trust Co. Invests $701,000 in Gilead Sciences, Inc. $GILD - Zolmax
CoreCap Advisors LLC Raises Stake in Gilead Sciences, Inc. $GILD - Markets Daily
Dynamic Advisor Solutions LLC Raises Stock Position in Gilead Sciences, Inc. $GILD - Daily Political
Gilead Sciences Reports Strong Q2 Sales Growth Amid Losses from Acquisitions, ETPharma
Gilead Sciences (NASDAQ:GILD) Given New $123.00 Price Target at Royal Bank Of Canada
Gilead (GILD) Faces HIV Drug Access Criticism From AIDS Healthcare Foundation
Kymera Reports Narrower Loss In Q2 As Collaboration Revenue Jumps
Top Medical Stocks To Research - August 5th - Stock Observer
Gilead Sciences, Inc. Declares Quarterly Dividend of $0.82 (NASDAQ:GILD)
Needham & Company LLC Reiterates Buy Rating for Gilead Sciences (NASDAQ:GILD)
Gilead Sciences, Inc. (NASDAQ:GILD) Plans Quarterly Dividend of $0.82 - Stock Observer
Gilead Sciences (NASDAQ:GILD) Announces Quarterly Earnings Results - Stock Observer
Gilead Sciences (NASDAQ:GILD) Receives "Overweight" Rating from Cantor Fitzgerald - Stock Observer
Gilead's Steady Long-Term Growth Prospects in HIV and Expansion in Oncology Support a Wide Moat | Morningstar
Gilead Sciences (NASDAQ:GILD) Issues Earnings Results, Beats Estimates By $0.51 EPS
Gilead Sciences Q2 Earnings Call Highlights
CORRECTING and REPLACING Gilead Sciences Announces Second Quarter 2026 Financial Results
Insider Selling: Gilead Sciences (NASDAQ:GILD) CEO Sells 15,000 Shares of Stock
Gilead Sciences Swings to 2Q Loss on R&D Costs, HIV-Drug Sales Lift Revenue | Morningstar
Gilead Swings To Q2 Loss On Acquisition Charges
Gilead second-quarter sales rise 8%, beating Wall Street estimates
Gilead Sciences (NASDAQ:GILD) Releases Quarterly Earnings Results, Beats Expectations By $0.51 EPS - Daily Political
GILD Q2 2026 Earnings Report on 8/3/2026
Could Gilead Sciences (GILD) Have a Major HIV Growth Engine in Yeztugo?
Gilead Sciences (NASDAQ:GILD) Issues FY 2026 Earnings Guidance - Daily Political
Medical Stocks To Follow Now - August 4th - Stock Observer
Trilogy Capital Inc. Purchases 9,777 Shares of Gilead Sciences, Inc. $GILD
Rani Therapeutics Appoints Michelle Gilson to Board of Directors
Lombard Odier Asset Management Europe Ltd Sells 7,604 Shares of Gilead Sciences, Inc. $GILD - Zolmax
CX Institutional Trims Holdings in Gilead Sciences, Inc. $GILD - Zolmax
CX Institutional Has $7.37 Million Stock Holdings in Gilead Sciences, Inc. $GILD
Confluence Investment Management LLC Trims Holdings in Gilead Sciences, Inc. $GILD
Lombard Odier Asset Management Europe Ltd Has $1.73 Million Stock Holdings in Gilead Sciences, Inc. $GILD - Daily Political
Gilead Sciences (GILD) Q2 Earnings Report Preview: What To Look For
Merck Spotlights Weekly HIV Treatment, Monthly PrEP as $5B Growth Opportunity - Daily Political
Sapient Capital LLC Has $22.68 Million Position in Gilead Sciences, Inc. $GILD
Promising Medical Stocks To Research - August 3rd - Daily Political
Gilead Sciences, Inc. $GILD Shares Sold by Pacer Advisors Inc. - Stock Observer
Best Biotech Stocks To Add to Your Watchlist - August 2nd - Stock Observer
Glenmede Trust Co. NA Trims Position in Gilead Sciences, Inc. $GILD
Gilead Sciences (NASDAQ:GILD) Downgraded by Wall Street Zen to "Hold"
Promising Medical Stocks To Add to Your Watchlist - August 1st - Daily Political
Gilead Sciences, Inc. $GILD Shares Sold by Groupama Asset Managment
Groupe la Francaise Increases Stake in Gilead Sciences, Inc. $GILD - Zolmax
Gilead Sciences (NASDAQ:GILD) Lowered to "Hold" Rating by Wall Street Zen
2 Large-Cap Stocks for Long-Term Investors and 1 Facing Challenges
Norris Financial Group LLC Makes New Investment in Gilead Sciences, Inc. $GILD
Janus Henderson Group PLC Has $274.92 Million Stake in Gilead Sciences, Inc. $GILD
Do Wall Street Analysts Like Gilead Sciences Stock?
Kentucky Retirement Systems Buys 48,403 Shares of Gilead Sciences, Inc. $GILD - Markets Daily
Hamilton Wealth LLC Buys 80,751 Shares of Gilead Sciences, Inc. $GILD - Markets Daily
Bank of America Corp DE Cuts Holdings in Gilead Sciences, Inc. $GILD
Caxton Associates LLP Sells 548,559 Shares of Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Shares Acquired by Arkadios Wealth Advisors
Gilead (GILD) Stock Stays Cheap On Its 130% Five Year Run
Hamilton Wealth LLC Purchases 80,751 Shares of Gilead Sciences, Inc. $GILD - Stock Observer
Gilead Sciences (GILD) Following Trodelvy Progress And A Fair Value Debate
Oddo BHF Asset Management Sas Purchases 11,575 Shares of Gilead Sciences, Inc. $GILD - Daily Political
Clinical toxicity of ADCs and ICI-ADC combinations: mechanisms, patterns and management
Barclays Issues Pessimistic Forecast for Gilead Sciences (NASDAQ:GILD) Stock Price
FY2027 EPS Estimates for Gilead Sciences Lowered by Analyst - Zolmax
Erste Group Bank Predicts Gilead Sciences FY2027 Earnings
The Manufacturers Life Insurance Company Has $173.14 Million Stock Holdings in Gilead Sciences, Inc. $GILD - Markets Daily
Gilead Sciences, Inc. $GILD Shares Bought by Waverly Advisors LLC
Atea Pharmaceuticals Says Hepatitis C Drug Matches Gilead's in Pivotal Trial
Gilead Sciences, Inc. $GILD Position Boosted by Amundi
Invasive mold infection in pediatric acute lymphoblastic leukemia-a detailed analysis of the clinical trial AIEOP-BFM ALL2009
GILD: Future Returns Will Depend On HIV Franchise And Oncology Execution
Morgan Stanley says buy these quality stocks. They also pay dividends
Gilead Sciences (GILD) Expected to Post Quarterly Earnings on Monday
Gilead Sciences, Inc. $GILD Shares Bought by KCM Investment Advisors LLC
Quantinno Capital Management LP Buys 117,534 Shares of Gilead Sciences, Inc. $GILD - Markets Daily
Empowered Funds LLC Has $27.24 Million Stake in Gilead Sciences, Inc. $GILD - Zolmax
Empowered Funds LLC Increases Holdings in Gilead Sciences, Inc. $GILD - Daily Political
Morgan Stanley Has Lowered Expectations for Gilead Sciences (NASDAQ:GILD) Stock Price
AstraZeneca Pressure Puts Krystal Biotech, TG Therapeutics And Gilead Stocks In Focus
#Aids2026: Daily pill. Monthly pill. Six-monthly jab. Why choice matters
Wealth Alliance LLC Sells 4,400 Shares of Gilead Sciences, Inc. $GILD - Markets Daily
Orbimed Advisors LLC Buys New Shares in Gilead Sciences, Inc. $GILD
Wealth Alliance LLC Cuts Stake in Gilead Sciences, Inc. $GILD - Stock Observer
Gilead (GILD) Wins Key Europe Backing For Trodelvy In Triple Negative Breast Cancer
Gilead Sciences, Inc. $GILD Shares Sold by Lombard Odier Asset Management Europe Ltd - Daily Political
OMERS ADMINISTRATION Corp Has $162.10 Million Stake in Gilead Sciences, Inc. $GILD - Daily Political
Best Pharmaceutical Stocks To Watch Now - July 25th
Gilead Sciences (GILD) Gets a Hold from RBC Capital
Hilltop Holdings Inc. Sells 8,156 Shares of Gilead Sciences, Inc. $GILD
Hilltop Holdings Inc. Reduces Stake in Gilead Sciences, Inc. $GILD - Zolmax
Epoch Investment Partners Inc. Sells 47,960 Shares of Gilead Sciences, Inc. $GILD - Daily Political
Dai ichi Life Insurance Company Ltd Sells 13,858 Shares of Gilead Sciences, Inc. $GILD - Daily Political
Pharmaceutical Stocks Worth Watching - July 21st - Zolmax
PNC Financial Services Group Inc. Has $67.77 Million Stock Position in Gilead Sciences, Inc. $GILD - Markets Daily
Gilead News
S&P 500 Forecast and Predictions for 2026, 2027 and 2030, Can US Stocks Find a Second Wind?
Broadcom (AVGO) Stock Forecast 2026–2030: Can AI Growth Drive Further Gains?
Broadcom AVGO Stock Analysis 2026: Can AI Growth Justify the Price?
Latest news
Show more
Gold Price Today, August 7: XAU/USD Holds Near $4,250 Before US Jobs Report
Western Digital Stock Falls 13% and Sandisk Slides 7% as Guidance Disappoints
SpaceX Stock Jumps 6% on $100 Billion Unlock Day as Earlier Selloff Absorbs Supply Shock
Alphabet Stock Falls as AI Leadership Changes and $25 Billion Bond Sale Raise Spending Questions
AVGO Stock News Today: Broadcom Gains as AI Chip Momentum and September Earnings Move Into Focus
